
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Recbio(HKEX:02179) is an innovative vaccine company founded in 2012. With the vision of Become the Leader of Innovative Vaccine in the Future, Recbio takes Protect Human Health with Best-in-Class Vaccines as its mission. It has established three major cutting-edge technology platforms including novel adjuvants platform, protein engineering platform, and immunological evaluation platform. Recbio has a high-value vaccine portfolio consisted of recombinant protein, HPV vaccine candidates, COVID-19 vaccine candidates, shingles vaccine candidates, influenza vaccine candidates, adults TB vaccine candidates, etc. The core scientific team has more than 20 years of experience in the development and commercialization of innovative vaccines. For more...
Vaccine,adjuvant,hpv vaccine,and covid19 vaccine
Recbio operates in the Biotechnology industry.
Recbio's revenue is 11m - 100m
Recbio has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.